Steven Monda
Tracked across 1 events · 6 articles · First seen Jul 02, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Steven Monda, a study author, provided expert commentary on the utility of the Prolaris Biopsy Test, highlighting its value in active surveillance conversations for low-risk prostate cancer patients.
Jul 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Steven Monda live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard